Topic Review
Transdermal Delivery of Chemotherapeutics
Chemotherapeutic drugs are primarily administered to cancer patients via oral or parenteral routes. The use of transdermal drug delivery could potentially be a better alternative to decrease the dose frequency and severity of adverse or toxic effects associated with oral or parenteral administration of chemotherapeutic drugs. The transdermal delivery of drugs has shown to be advantageous for the treatment of highly localized tumors in certain types of breast and skin cancers. In addition, the transdermal route can be used to deliver low-dose chemotherapeutics in a sustained manner. The transdermal route can also be utilized for vaccine design in cancer management, for example, vaccines against cervical cancer. However, the design of transdermal formulations may be challenging in terms of the conjugation chemistry of the molecules and the sustained and reproducible delivery of therapeutically efficacious doses.
  • 458
  • 04 Aug 2021
Topic Review
High-Grade Gliomas
High-grade glioma (HGG)'s treatment development is hampered by (1) the blood–brain barrier (BBB), (2) an infiltrative growth pattern, (3) rapid development of therapeutic resistance, and, in many cases, (4) dose-limiting toxicity due to systemic exposure. Convection-enhanced delivery (CED) has the potential to significantly limit systemic toxicity and increase therapeutic index by directly delivering homogenous drug concentrations to the site of disease.
  • 457
  • 05 May 2021
Topic Review
Cytochrome Inhibitors
Major cytochrome inhibitors may result in drug–drug interactions.
  • 456
  • 08 Jun 2021
Topic Review
Cephalaria (Caprifoliaceae) Genus
The genus Cephalaria, belonging to the Caprifoliaceae family, is a rich source of interesting secondary metabolites, including mainly saponins which display a variety of biological activities, such as immunomodulatory, antimicrobial and hemolytic effects.
  • 456
  • 02 Jul 2021
Topic Review
Solid Lipid Nanoparticles/Nanostructured Lipid Carriers in Acne VulgarisTreatment
Acne vulgaris (acne) is one of the most common dermatological problems affecting adolescents and young adults. Although acne may not lead to serious medical complications, its psychosocial effects are tremendous and scientifically proven. The first-line treatment for acne is topical medications composed of synthetic compounds, which usually cause skin irritation, dryness and itch. Therefore, naturally occurring constituents from plants (phytochemicals), which are generally regarded as safe, have received much attention as an alternative source of treatment. However, the degradation of phytochemicals under high temperature, light and oxygen, and their poor penetration across the skin barrier limit their application in dermatology. Encapsulation in lipid nanoparticles is one of the strategies commonly used to deliver drugs and phytochemicals because it allows appropriate concentrations of these substances to be delivered to the site of action with minimal side effects. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are promising delivery systems developed from the combination of lipid and emulsifier. They have numerous advantages that include biocompatibility and biodegradability of lipid materials, enhancement of drug solubility and stability, ease of modulation of drug release, ease of scale-up, feasibility of incorporation of both hydrophilic and lipophilic drugs and occlusive moisturization, which make them very attractive carriers for delivery of bioactive compounds for treating skin ailments such as acne.
  • 455
  • 24 Jun 2022
Topic Review
Fluoroquinolones Used in Therapy
Antibacterial fluoroquinolones (FQs) are frequently used in treating infections. However, the value of FQs is debatable due to their association with severe adverse effects (AEs). The Food and Drug Administration (FDA) issued safety warnings concerning their side-effects in 2008, followed by the European Medicine Agency (EMA) and regulatory authorities from other countries.
  • 455
  • 17 Mar 2023
Topic Review
Pharmacomicrobiomics and Drug–Infection Interactions
Microorganisms have a close relationship with humans, whether it is commensal, symbiotic, or pathogenic. It has been documented that microorganisms may influence the response to drug therapy. Pharmacomicrobiomics is an emerging field that focuses on the study of how variations in the microbiome affect the disposition, action, and toxicity of drugs. Two additional sciences have been added to complement pharmacomicrobiomics, namely toxicomicrobiomics, which explores how the microbiome influences drug metabolism and toxicity, and pharmacoecology, which refers to modifications in the microbiome as a result of drug administration. Additionally, the concept of "drug-infection interaction" is included to describe the influence of pathogenic microorganisms on drug response. This entry analyzes in detail each of these concepts.
  • 454
  • 05 Jan 2024
Topic Review
Elevated Procalcitonin and COVID-19
PCT is a precursor of calcitonin, which is secreted by neuroendocrine cells such as C cells of the thyroid and pancreatic tissues.  PCT plays an important role in the diagnosis of systemic bacterial infection.  Elevated serum PCT levels have also been reported in patients with pulmonary infection. Additionally, the positive feedback between procalcitonin and proinflammatory cytokines subsequently culminates in a severe systemic inflammatory response.  
  • 453
  • 23 Jun 2021
Topic Review
The Pharmacological Therapies of Huntington’s Chorea
Huntington’s Disease (HD) is an autosomal, dominantly inherited neurodegenerative disorder caused by an expansion of the CAG repeat in the huntingtin (HTT) gene. The disease generally manifests during mid-life and is clinically characterized by involuntary movements (chorea), psychiatric and behavioral symptoms, and cognitive decline. To this date, no cure or disease-modifying therapy exists. However, a wide variety of pharmacological therapies are used to improve quality of life.
  • 453
  • 23 May 2022
Topic Review
Hepatic CYP2E1 in Causal Toxicity and Treatment Options
Cytochrome P450 2E1 (CYP2E1), one of the major metabolizing enzymes in humans, is mainly expressed in the liver. Alcohol and several therapeutic drugs, including acetaminophen, are metabolized by CYP2E1 into toxic compounds. At low levels, these compounds are not detrimental, but higher sustained levels of these compounds can lead to life-long problems such as cytotoxicity, organ damage, and cancer. Furthermore, CYP2E1 can facilitate or enhance the effects of alcohol-drug and drug-drug interactions.
  • 453
  • 13 Sep 2022
  • Page
  • of
  • 106
Video Production Service